| Addition of Ipilimumab (MDX-010) To Isolated Limb Infusion (ILI) With Standard Melphalan and Dactinomycin In The Treatment of Advanced Unresectable Melanoma of The Extremity (NCT01323517) | Memorial Sloan Kettering Cancer Center | 2011-02-01 |
| Evaluation of a New Anti-cancer Immunotherapy in Patients With Non-operable and Progressing Metastatic Cutaneous Melanoma (NCT01213472) | GlaxoSmithKline | 2011-01-31 |
| cKIT, BRAF/NRAS Mutations in Advanced Melanoma : Clinical Outcome in Response to Tyrosine-kinase Inhibitors - KitMel Project (NCT01543113) | Rennes University Hospital | 2011-01-01 |
| Combination Therapy of Topical Imiquimod Plus Multipeptide Vaccination for Cutaneous Metastases of Melanoma (NCT01264731) | University of Virginia | 2011-01-01 |
| Safety and Efficacy Study of BMS-908662 in Combination With Ipilimumab in Subjects With Advanced Melanoma (NCT01245556) | Bristol-Myers Squibb | 2011-01-01 |
| Role of SLURP-1 in Melanoma and Melanoma Stem Cells (NCT01281722) | National Taiwan University Hospital | 2011-01-01 |
| Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer (NCT01065441) | Michael Har-Noy | 2010-12-01 |
| A Safety and MORAb-028 Dose Determination Study in Subjects With Metastatic Melanoma (NCT01212276) | Morphotek | 2010-12-01 |
| Genasense, Carboplatin, Paclitaxel (GCP) Combination in Uveal Melanoma (NCT01200342) | M.D. Anderson Cancer Center | 2010-12-01 |
| GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma (NCT01245062) | GlaxoSmithKline | 2010-11-22 |
| Combination of Anti-CD137 & Ipilimumab in Patients With Melanoma (NCT00803374) | Bristol-Myers Squibb | 2010-11-01 |
| Randomized Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy (NCT01223248) | Memorial Sloan Kettering Cancer Center | 2010-10-01 |
| Docetaxel With or Without AZD6244 in Melanoma (NCT01256359) | University of Oxford | 2010-10-01 |
| An Extended Use Study of Safety and Efficacy of Talimogene Laherparepvec in Melanoma (NCT01368276) | BioVex Limited | 2010-10-01 |
| Safety Study of Adjuvant Vaccine to Treat Melanoma Patients (NCT01079741) | Nina Bhardwaj | 2010-09-01 |
| An Expanded Cohort Trial of Bortezomib and Sorafenib in Advanced Malignant Melanoma (NCT01078961) | Massachusetts General Hospital | 2010-09-01 |
| NIR-Guided Sentinel Lymph Node Mapping in Melanoma (NCT01121718) | Dana-Farber Cancer Institute | 2010-09-01 |
| IMCgp100 in Advanced Unresectable Melanoma (NCT01209676) | University of Pennsylvania | 2010-09-01 |
| A Study of GSK2118436 in BRAF Mutant Metastatic Melanoma (NCT01153763) | GlaxoSmithKline | 2010-08-09 |
| Phase II Study of Interleukin-21 (rIL-21) vs Dacarbazine (DTIC) in Patients With Metastatic or Recurrent Melanoma (NCT01152788) | NCIC Clinical Trials Group | 2010-08-05 |
| Evaluation of a New Vaccine Treatment for Patients With Metastatic Skin Cancer (NCT01149343) | GlaxoSmithKline | 2010-07-02 |
| A Two Arm Trial of Axitinib and Carboplatin/Paclitaxel in Melanoma (NCT01174238) | Adil Daud | 2010-07-01 |
| Safety and Efficacy Study of Electrotransfer of Plasmid AMEP to Treat Advanced or Metastatic Melanoma (NCT01045915) | Valerio Therapeutics | 2010-07-01 |
| Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment (NCT01205815) | Vanderbilt-Ingram Cancer Center | 2010-06-03 |
| A Study of AMNN107 in the Treatment of Metastatic and/or Inoperable Melanoma Harboring a c-Kit Mutation (NCT01028222) | Novartis Pharmaceuticals | 2010-06-01 |
| Breast and Melanoma Trial With Lymphoseek to Identify Lymph Nodes (NCT01106040) | Navidea Biopharmaceuticals | 2010-06-01 |
| Immunotherapy of HLA-A2 Positive Stage II-IV Melanoma Patients (NCT01308294) | Centre Hospitalier Universitaire Vaudois | 2010-06-01 |
| Tumor and Vaccine Site With a Toll Like Receptor (TLR) Agonist (NCT00960752) | M.D. Anderson Cancer Center | 2010-05-20 |
| SCRI Tissue Testing Registry (NCT00965861) | SCRI Development Innovations, LLC | 2010-05-01 |
| Safety Study of Human IgM (MORAb-028) to Treat Metastatic Melanoma (NCT01123304) | Morphotek | 2010-05-01 |
| MelaViD: A Trial on Vitamin D Supplementation for Resected Stage II Melanoma Patients (NCT01264874) | European Institute of Oncology | 2010-05-01 |
| Yttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver Metastases (NCT01290536) | Nicholas Fidelman, MD | 2010-05-01 |
| Single-step Antigen Loading and TLR Activation of Dendritic Cells in Melanoma Patients (NCT01530698) | Radboud University Medical Center | 2010-04-01 |
| Prospective Randomized Comparative Study of Cell Transfer Therapy Using CD8+-Enriched Short-Term Cultured Anti-Tumor Autologous Lymphocytes Following a Non-Myeloablative Lymphocyte Depleting Chemotherapy Regimen Compared to High-Dose Aldesleukin in M... (NCT01118091) | National Cancer Institute (NCI) | 2010-04-01 |
| Interstitial Fluid Pressure (IFP) Pilot Study in Melanoma Patients (NCT01003626) | M.D. Anderson Cancer Center | 2010-03-01 |
| Disulfiram and Chelated Zinc for the Rx of Disseminated Mets Mel That Has Failed First Line Therapy (NCT02101008) | University of Utah | 2010-03-01 |
| Use of Fiber-optic Probe for Non-invasive Diagnosis of Melanoma and Assessment of Impact of Ultraviolet (UV) Exposure on Skin (NCT01085396) | University of Pittsburgh | 2010-03-01 |
| A Clinical Study, to Evaluate the Safety and Tolerability of Intradermal IMM-101 in Adult Melanoma Cancer Patients (NCT01308762) | Immodulon Therapeutics Ltd | 2010-03-01 |
| A Phase I Study of TPI 287 - Temozolomide Combination in Melanoma (NCT01067066) | M.D. Anderson Cancer Center | 2010-02-03 |
| Tesetaxel as Second-line Therapy for Patients With Advanced Melanoma and Normal Serum LDH (NCT01092585) | Genta Incorporated | 2010-02-01 |
| A Study on the Safety and Immunogenicity of Combined Intradermal and Intravenous Administration of an Autologous mRNA Electroporated Dendritic Cell Vaccine in Patients With Previously Treated Unresectable Stage III or IV Melanoma (NCT01066390) | Bart Neyns | 2009-12-01 |
| Study of Weekly LOC-paclitaxel Injection for Melanoma (NCT01039844) | M.D. Anderson Cancer Center | 2009-12-01 |
| Evaluation of Interferon-Lovastatin Therapy for Malignant Melanoma (NCT00963664) | NeoPlas Innovation | 2009-12-01 |
| A Study of Tasisulam-sodium Versus Paclitaxel as Treatment for Metastatic Melanoma (NCT01006252) | Eli Lilly and Company | 2009-12-01 |
| Immunogenicity and Biomarker Analysis of Neoadjuvant Ipilimumab for Melanoma (NCT00972933) | Diwakar Davar | 2009-12-01 |
| A Phase I Study of Intravenous Recombinant Human IL-15 in Adults With Refractory Metastatic Malignant Melanoma and Metastatic Renal Cell Cancer (NCT01021059) | National Cancer Institute (NCI) | 2009-11-10 |
| Determining the Lymphokine Activated Killer (LAK) Cytotoxicity Present in Patients Undergoing Interleukin-2 Therapy (NCT01068470) | Loma Linda University | 2009-11-01 |
| Temozolomide Plus Bevacizumab in Patients With Metastatic Melanoma Involving the Central Nervous System (NCT01048554) | Mt. Sinai Medical Center, Miami | 2009-11-01 |
| Evaluating the Safety and the Biological Effects of Intratumoral Interferon Gamma and a Peptide-Based Vaccine in Patients With Melanoma (NCT00977145) | Craig L Slingluff, Jr | 2009-11-01 |
| A Study of YM155 Plus Docetaxel in Subjects With Stage III (Unresectable) or Stage IV Melanoma (NCT01009775) | Astellas Pharma Inc | 2009-11-01 |
| Phase I Oncovir Poly IC:LC and NY-ESO-1/gp100 (NCT01008527) | H. Lee Moffitt Cancer Center and Research Institute | 2009-10-01 |
| Survey Study - Sensitivity Comparison Between MelaFind and Physician Group (NCT01011153) | MELA Sciences, Inc. | 2009-10-01 |
| Using High Resolution Function Imaging To Detect Melanoma and Dysplastic Nevi (NCT01118832) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2009-09-22 |
| Cisplatin, Temozolomide, Abraxane, With Interleukin-2 and Interferon for Metastatic Melanoma (NCT00970996) | M.D. Anderson Cancer Center | 2009-09-01 |
| Pilot Study of IFN α2b for Melanoma Patients (NCT00871533) | University of Pittsburgh | 2009-09-01 |
| Safety Study of a Liposomal Vaccine to Treat Malignant Melanoma (NCT01052142) | Lipotek Pty Ltd | 2009-09-01 |
| Neurotropic Melanoma of the Head and Neck (NCT00975520) | Melanoma and Skin Cancer Trials Limited | 2009-09-01 |
| A Study to Test the Benefit of a New Anti-cancer Treatment in Patients With Unresectable Advanced Melanoma (NCT00942162) | GlaxoSmithKline | 2009-08-14 |
| Carboplatin, Paclitaxel, and Temozolomide for Patients With Metastatic Melanoma (NCT01009515) | New Mexico Cancer Research Alliance | 2009-08-01 |
| Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment (NCT02105168) | Gustave Roussy, Cancer Campus, Grand Paris | 2009-07-01 |
| Vaccination of Melanoma Patients With Total or CD25-depleted Peripheral Blood Mononuclear Cell (PBMC) (NCT00961376) | Providence Health & Services | 2009-07-01 |
| Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies (NCT00923026) | National Cancer Institute (NCI) | 2009-06-15 |
| Toll-like Receptor (TLR) Ligand Matured Dendritic Cell Vaccination in Melanoma Patients (NCT00940004) | Radboud University Medical Center | 2009-06-01 |
| T-cell Based Immunotherapy for of Melanoma (NCT00937625) | Inge Marie Svane | 2009-06-01 |
| Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer (NCT01526486) | Emory University | 2009-06-01 |
| A Study of Safety and Clinical Activity of Immunotherapy Plus Chemotherapy in Metastatic Melanoma Patients (NCT00849875) | GlaxoSmithKline | 2009-05-26 |
| Study of GSK2132231A Antigen-Specific Cancer Immunotherapeutic in Patients With Inoperable Metastatic Cutaneous Melanoma (NCT00896480) | GlaxoSmithKline | 2009-05-19 |
| Pain Prevalence and Risk Factors Among Sarcoma/Melanoma Oncology Patients in an Outpatients Setting (NCT01034696) | Royal Marsden NHS Foundation Trust | 2009-05-01 |
| Efficacy Study Of P276-00 In Subjects Of Malignant Melanoma Positive For Cyclin D1 Expression (NCT00835419) | Piramal Enterprises Limited | 2009-05-01 |
| Genetic Variates of Response to Cisplatin, Vinblastine, and Temozolomide (CVT) in Patients With Metastatic Melanoma (NCT00885534) | Memorial Sloan Kettering Cancer Center | 2009-04-01 |
| Trial of an Intratumoral Injections of INXN-3001 in Subjects With Stage III or IV Melanoma (NCT00815607) | Alaunos Therapeutics | 2009-04-01 |
| Efficacy and Safety Study of Talimogene Laherparepvec Compared to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in Melanoma (NCT00769704) | BioVex Limited | 2009-04-01 |
| Adjuvant Therapy of Pegylated Interferon- 2b Plus Melanoma Peptide Vaccine (NCT00861406) | M.D. Anderson Cancer Center | 2009-03-10 |
| Bevacizumab Plus Ipilimumab in Patients With Unresectable Stage III or IV Melanoma (NCT00790010) | Dana-Farber Cancer Institute | 2009-02-26 |
| Haploidentical NK Cell Infusion in Malignant Melanoma (NCT00846833) | Seoul National University Hospital | 2009-02-01 |
| A Study Evaluating Efficacy of ABT-888 in Combination With Temozolomide in Metastatic Melanoma (NCT00804908) | AbbVie (prior sponsor, Abbott) | 2009-02-01 |
| Hepatic Arterial Infusion of Nab-Paclitaxel in Patients With Metastatic Melanoma in the Liver (NCT00833807) | M.D. Anderson Cancer Center | 2009-02-01 |
| Exploratory Study of Natural Killer Cells in Human Skin (NCT00824889) | Assistance Publique Hopitaux De Marseille | 2009-02-01 |
| Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged Melanoma (NCT00788775) | Dana-Farber Cancer Institute | 2009-01-23 |
| Comparison of Video-Based Versus Written Patient Education on Melanoma (NCT00826995) | University of California, Davis | 2009-01-01 |
| Ultraviolet Light Exposure and Immunosuppression in Cutaneous Melanoma (NCT00996827) | New Mexico Cancer Research Alliance | 2009-01-01 |
| Feasibility and Functionality of fPAM Imaging in Melanoma (NCT00776945) | Washington University School of Medicine | 2009-01-01 |
| Radiation, Chemotherapy, Vaccine and Anti-MART-1 and Anti-gp100 Cells for Patients With Metastatic Melanoma (NCT00923195) | National Cancer Institute (NCI) | 2008-12-01 |
| A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor (NCT00796445) | GlaxoSmithKline | 2008-12-01 |
| The Response of Serum 25-Hydroxyvitamin D to Incidental Ultraviolet Light Exposure (NCT00832533) | New Mexico Cancer Research Alliance | 2008-11-01 |
| A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma, Ewing Sarcoma and Melanoma (NCT00743496) | St. Jude Children's Research Hospital | 2008-10-08 |
| Genetic Risk Factors and Acquired Oncogenic Mutations of Melanoma (NCT00849407) | Medical University of Vienna | 2008-10-01 |
| Comparative Study of Individualized Sensitivity-Directed Chemotherapy Versus DTIC (NCT00779714) | University of Wuerzburg | 2008-10-01 |
| MAGE-A3 Antigen-Specific Cancer Immunotherapeutic in Patients With Progressive Metastatic Cutaneous Melanoma (NCT00706238) | GlaxoSmithKline | 2008-09-29 |
| Parallel Phase I/II Trial of Decitabine and Peg-Interferon in Melanoma: Phase I Portion (NCT00791271) | M.D. Anderson Cancer Center | 2008-09-02 |
| Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases (NCT00769990) | Masonic Cancer Center, University of Minnesota | 2008-09-01 |
| In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis (NCT00785369) | Lucid, Inc. | 2008-08-01 |
| An Extension Protocol for the Extended Use of Talimogene Laherparepvec for Eligible Patients Who Participated in Study 002/03 (NCT00289016) (NCT02574260) | BioVex Limited | 2008-08-01 |
| Illness Related Distress in Women With Clinically Localized Cutaneous Melanoma (NCT00745862) | Memorial Sloan Kettering Cancer Center | 2008-08-01 |
| Efficacy Study of TLN-232 in Patients With Recurring Metastatic Melanoma (NCT00735332) | Thallion Pharmaceuticals | 2008-08-01 |
| Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5 (NCT00743353) | Siemens Molecular Imaging | 2008-08-01 |
| Dendritic Cells (White Blood Cells) Vaccination for Advanced Melanoma (NCT00683670) | University of Pennsylvania | 2008-08-01 |
| Clinical Research on the Treatments on Advanced Malignant Melanoma by Combining in Situ Immunotherapy and Laser Therapy (NCT02372708) | Chinese PLA General Hospital | 2008-08-01 |
| A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002) (NCT00753415) | Merck Sharp & Dohme LLC | 2008-08-01 |
| Cognitive Effects of Interferon in Patients With Melanoma (NCT02074605) | University of Arizona | 2008-07-01 |